Literature DB >> 27655552

[Research progress in relationship between fractional exhaled nitric oxide and asthma in children].

Jing Zeng1, Wei Liao.   

Abstract

Bronchial asthma is a heterogeneous disease that is characterized by airway hyperresponsiveness and chronic inflammation. It is often accompanied by reversible airflow obstruction. Current laboratory testing methods for the diagnosis of asthma in children mainly include lung ventilation function test. Due to the non-cooperation of children, it is very challenging to conduct lung ventilation function test for preschoolers. Lung function testing is an instantaneous indicator, which is influenced by the children's understanding ability and mental factors. In addition, it could not assess the severity of airway inflammation. Fractional exhaled nitric oxide (FeNO) is a noninvasive, simple, and objective indicator of airway inflammation and has gradually gained increased use in children in recent years. This review article introduces the source of FeNO, the reference value of FeNO in laboratory testing, and the progress in the application of FeNO in the diagnosis, prediction, and treatment of asthma in children of various ages.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27655552      PMCID: PMC7389960     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  35 in total

1.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

2.  [Related factors for asthmatic children's responses to long-term treatment].

Authors:  Xiao-Ying Liu; Jing Wang; Qun Wang; Yi-Xin Ren; Yong-Ge Liu; Qing Miao; Zhen Li; Li Xiang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2015-07

3.  Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.

Authors:  Haijin Zhao; Rui Li; Yanhua Lv; Hangming Dong; Lihong Yao; Yue Wu; Guanhua Xiao; Shaoxi Cai
Journal:  Clin Respir J       Date:  2015-07-08       Impact factor: 2.570

4.  Diagnostic value of exhaled nitric oxide in childhood asthma and allergy.

Authors:  C Sachs-Olsen; K C Lødrup Carlsen; P Mowinckel; G Håland; C S Devulapalli; M C Munthe-Kaas; K-H Carlsen
Journal:  Pediatr Allergy Immunol       Date:  2010-02       Impact factor: 6.377

5.  Utility of nitric oxide for the diagnosis of asthma in an allergy clinic population.

Authors:  Danielle Cordeiro; Arjan Rudolphus; Erik Snoey; Gert-Jan Braunstahl
Journal:  Allergy Asthma Proc       Date:  2011 Mar-Apr       Impact factor: 2.587

6.  FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management.

Authors:  Marcello Verini; Nicola Pietro Consilvio; Sabrina Di Pillo; Anna Cingolani; Cynzia Spagnuolo; Daniele Rapino; Alessandra Scaparrotta; Francesco Chiarelli
Journal:  J Allergy (Cairo)       Date:  2010-05-18

7.  Changes of exhaled nitric oxide during steroid treatment of childhood asthma.

Authors:  J Beck-Ripp; M Griese; S Arenz; C Köring; B Pasqualoni; P Bufler
Journal:  Eur Respir J       Date:  2002-06       Impact factor: 16.671

8.  Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.

Authors:  Paolo Montuschi; Chiara Mondino; Pierluigi Koch; Giovanni Ciabattoni; Peter J Barnes; Giuseppe Baviera
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

9.  Effect of intubation and mechanical ventilation on exhaled nitric oxide in preterm infants with and without bronchopulmonary dysplasia measured at a median postmenstrual age of 49 weeks.

Authors:  Gerd Schmalisch; Silke Wilitzki; Hendrik S Fischer; Christoph Bührer
Journal:  BMC Res Notes       Date:  2014-06-24

10.  Association between the Asthma Predictive Index and levels of exhaled nitric oxide in infants and toddlers with recurrent wheezing.

Authors:  Juan Emilio Balinotti; Alejandro Colom; Carlos Kofman; Alejandro Teper
Journal:  Arch Argent Pediatr       Date:  2013-06       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.